KMT2A and lung adenocarcinoma: Collectively, these findings identify a previously unappreciated enrichment of NOTCH signaling in tumor-associated monocytes/macrophages and implicate KMT2A as a key transcriptional regulator in these cells, potentially offering new opportunities for targeting myeloid cell functions in lung adenocarcinoma.